(In thousands, except per share amounts)
(unaudited)
Three Months Ended March 31, | ||||||||
2023 | 2022 | |||||||
GAAP net income (loss) | $ | (53,842 | ) | $ | 71,904 | |||
Stock-based compensation related charges (1) | 33,111 | 56,088 | ||||||
Acquisition-related costs (2) | — | 172 | ||||||
Amortization expense of acquired intangible assets | 443 | 260 | ||||||
Change in fair value of warrants liability (3) | (222 | ) | (21,433 | ) | ||||
Change in fair value of contingent earn-out liability (4) | — | (136,043 | ) | |||||
Payroll tax related to contingent earn-out share issuance (5) | — | 1,164 | ||||||
Non-GAAP net loss | $ | (20,510 | ) | $ | (27,888 | ) | ||
GAAP net income (loss) per share attributable to common stockholders: | ||||||||
Basic | $ | (0.18 | ) | $ | 0.26 | |||
Diluted | $ | (0.18 | ) | $ | 0.23 | |||
Non-GAAP net loss per share attributable to common stockholders, basic and diluted | $ | (0.07 | ) | $ | (0.10 | ) | ||
Weighted-average shares used to compute GAAP net income (loss) per share, basic | 293,074 | 275,199 | ||||||
Weighted-average effect of potentially dilutive securities (6) | — | 37,233 | ||||||
Weighted-average shares used to compute GAAP net income (loss) per share, diluted | 293,074 | 312,432 | ||||||
Excluded anti-dilutive weighted-average potential shares of common stock in calculating non-GAAP loss per share | — | (37,233 | ) | |||||
Weighted-average shares used to compute non-GAAP net loss per share, basic and diluted | 293,074 | 275,199 |